Giramsan Pharmaceuticals Private Limited
About Giramsan Pharmaceuticals Private Limited
Data last updated:
Giramsan Pharmaceuticals Private Limited is a private limited company based in Sagar, Madhya Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 03 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2018PTC046769. Its GSTIN is 23AAHCG4856E1ZP (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prem Singh Kurmi and Abhilasha Kurmi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 8/17 Dharmashree Tigadda Ambedkar Ward Near Saroj Hotel, Sagar, Madhya Pradesh, India – 470002.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.73 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹1,834 (net margin 0.2%) and EBITDA of ₹3,262 (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 11% over five years.
Company details
Contact details
Giramsan Pharmaceuticals Private Limited's registered office is in Sagar, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. 8/17 Dharmashree Tigadda Ambedkar Ward Near Saroj Hotel, Sagar, Madhya Pradesh, India – 470002
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Giramsan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Giramsan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Giramsan Pharmaceuticals Private Limited, buy the company report.
Financials of Giramsan Pharmaceuticals Private Limited
FY 2025 filings availableGiramsan Pharmaceuticals Private Limited reported revenue of ₹9.73 Lakh (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,262 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,834 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Giramsan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Giramsan Pharmaceuticals Private Limited
Giramsan Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prem Singh Kurmi | Director | 03 Oct 2018 | 8 Years 1 Months | Current |
| Abhilasha Kurmi | Director | 03 Oct 2018 | 8 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Giramsan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Giramsan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Giramsan Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAHCG4856E1ZP | Madhya Pradesh | Active | 22 May 2019 |
To see the full GST registrations and return filing status of Giramsan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Giramsan Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Abhilasha Kurmi was appointed as Director on 03 Oct 2018.
Frequently asked questions
Giramsan Pharmaceuticals is an active private limited company based in Sagar, Madhya Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 03 October 2018 (8+ years old) and is registered under CIN U51909MP2018PTC046769.
Giramsan Pharmaceuticals has 2 current directors:
- Prem Singh Kurmi - Director
- Abhilasha Kurmi - Director
The latest financial statements of Giramsan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Giramsan Pharmaceuticals is 23AAHCG4856E1ZP, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Giramsan Pharmaceuticals is U51909MP2018PTC046769. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Giramsan Pharmaceuticals was incorporated on 03 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
Abhilasha Kurmi was appointed as Director on 03 Oct 2018. Prem Singh Kurmi was appointed as Director on 03 Oct 2018.
The registered office of Giramsan Pharmaceuticals is at H.No. 817 Dharmashree Tigadda Ambedkar Ward Near Saroj Hotel, Sagar, Madhya Pradesh, India – 470002.
Giramsan Pharmaceuticals operates in the trading industry, in the specialty segment.
Giramsan Pharmaceuticals can be reached at its registered office: H.No. 817 Dharmashree Tigadda Ambedkar Ward Near Saroj Hotel, Sagar, Madhya Pradesh, India – 470002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
